Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...

Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...

Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby group ...

Denmark is reportedly open to the idea of meeting with U.S. President-elect Donald Trump to discuss the future of Greenland. According to two sources who spoke to Axios, Danish officials have sent ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Tariffs on Denmark would likely affect Americans' access ... Americans are already paying far more for the diabetes and weight loss medication than other countries, and Novo's most recent ...

it would require a 4lb weight-loss – the equivalent of around 14,000 calories, or the total weekly recommended calorie intake for a woman. Clearly, we can’t achieve this through calorie ...